Access to all functionalities is reserved for healthcare professionals.
If you are a healthcare professional, you must log in or register for free on our site to access all of our content. If you are a journalist or would like to contact us, write to [email protected].
As of December 19th, 2025, Belgium had administered 1,923,000 flu vaccines, exceeding last year’s figures by over 100,000 doses. Specifically,481,132 vaccinations were given in Wallonia,representing a 6.45% increase year-over-year, according to walloon Health Minister Yves coppieters.
The Minister addressed concerns regarding pharmacy stock shortages during a regional parliamentary session on wednesday. He explained that the current strain on flu vaccine supply is linked to Belgium’s distribution structure and a significant surge in demand this season. Pharmacists, wholesalers, and institutional actors placed pre-orders between January and March, based on the previous year’s volumes, which then initiate the production process.
Production doesn’t begin until May, following strain selection, with vaccines becoming available in the autumn. While last year’s vaccine distribution quantities were considered, and subsequent orders were increased, they proved insufficient to meet the heightened demand. Though, the Minister highlighted the positive trend of increased vaccination coverage.
Understanding the Flu Vaccine Landscape in 2026
I’ve found that understanding the complexities of vaccine distribution is crucial, especially during periods of high demand. The process, as described by Minister Coppieters, is a delicate balance between forecasting, production, and timely delivery. This year’s situation underscores the importance of proactive planning and flexible supply chains.
The expansion of pharmacy-based vaccinations has played a significant role in improving accessibility, resulting in a 38% increase in vaccinations administered in pharmacies. This shift towards more convenient access points is a key factor in boosting overall vaccination rates. It’s a trend we’re seeing globally, as patients increasingly prefer the ease and convenience of receiving vaccinations in familiar community settings.
Did you know? According to the CDC, the 2024-2025 influenza season saw a higher-than-average number of cases, perhaps contributing to the increased demand for vaccines this year.
Why Are Flu Vaccine Supplies Sometimes Limited?
Several factors can contribute to limited flu vaccine supplies.The manufacturing process is complex and time-consuming, requiring months of lead time. Predicting the dominant flu strains each year is also challenging, necessitating a flexible production approach. Unexpected surges in demand, like the one belgium experienced, can further strain the supply chain. Furthermore, global events and manufacturing disruptions can also play a role.
Here’s what works best: Encouraging early vaccination, ideally in October or November, can help alleviate pressure on the system and ensure that those who want a vaccine can receive one.
The increased accessibility through pharmacies is a positive step, but it also requires robust logistical support to ensure a consistent supply to these locations. It’s a challenge that requires collaboration between manufacturers, distributors, and healthcare providers.
Flu Vaccine Supply chain: A Closer look
The flu vaccine supply chain is a multi-stage process.It begins with the World Health Institution (WHO) identifying the circulating influenza strains and recommending vaccine compositions. Manufacturers then produce the vaccines, which are distributed to national health authorities and, ultimately, to healthcare providers. This process is subject to various regulatory requirements and quality control measures.
Here’s a
